StockWatch
·
Trading & Distributors
Business Update26 Mar 2026, 12:26 pm

Genpharmasec Ltd Announces Closure of Trading Window

AI Summary

Genpharmasec Ltd has announced the closure of its trading window for all designated persons and their immediate relatives. The closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct for Prevention of Insider Trading and Disclosure Practices. The trading window will remain closed from Wednesday, April 01, 2026 till 48 hours after the declaration of Audited Financial Results for the Quarter and Financial year ended March 31, 2026. All Promoter and Promoter group, Directors, KMP's, Designated Persons, Connected Persons of the Company and their immediate relatives are advised not to deal in the securities of the Company during this period. The date of the Board of Directors' meeting to consider and approve the Audited Financial Results will be intimated in due course.

Key Highlights

  • Genpharmasec Ltd announces closure of trading window
  • Closure in accordance with SEBI regulations and Company's Code of Conduct
  • Trading window to remain closed from April 01, 2026 till 48 hours after declaration of Audited Financial Results
  • All designated persons and their immediate relatives advised not to deal in securities during this period
  • Date of Board of Directors' meeting to consider and approve Audited Financial Results to be intimated later